| Belinda Ross, LPN | |
|
1 Long Wharf Dr, New Haven, CT 06511-5946 | |
| (203) 781-4600 | |
| (203) 781-4624 |
| Full Name | Belinda Ross |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 1 Long Wharf Dr, New Haven, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497162887 | NPI | - | NPPES |
| 004041000 | Medicaid | CT | |
| 004217099 | Medicaid | CT | |
| 008003745 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 032008 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Belinda Ross, LPN 1 Long Wharf Dr, New Haven, CT 06511-5946 Ph: (203) 781-4600 | Belinda Ross, LPN 1 Long Wharf Dr, New Haven, CT 06511-5946 Ph: (203) 781-4600 |
News Archive
Mayo Clinic researchers studied more than 200 children with epilepsy and found that even if the cause of focal-onset seizures cannot be identified and they do not fit into a known epilepsy syndrome, long-term prognosis is still excellent. This study was presented at the American Epilepsy Society's annual meeting in San Antonio on Dec. 4.
We live in fear of 'superbugs': infectious bacteria that don't respond to treatment by antibiotics, and can turn a routine hospital stay into a nightmare. A 2015 Health Canada report estimates that superbugs have already cost Canadians $1 billion, and are a "serious and growing issue." Each year two million people in the U.S. contract antibiotic-resistant infections, and at least 23,000 people die as a direct result.
There's no solid evidence that we sleep fewer hours today than we ever did, this is something I have gone into large amounts of detail in my book, in my published papers and at a recent meeting at the Royal Society of Medicine.
4SC, a drug discovery and development company focused on autoimmune and cancer indications, today announced that initial safety and efficacy data from its ongoing Phase II Study with resminostat, a pan-Histone Deacetylase (HDAC) Inhibitor, in relapsed/refractory Hodgkin Lymphoma (HL) patients after high dose chemotherapy and autologous hematopoietic stem cell transplantation will be presented at the 52nd Annual Meeting of the American Society of Hematology (ASH) in Orlando, Florida, USA.
› Verified 5 days ago
Heidi Clarke, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Long Wharf Dr, New Haven, CT 06511 Phone: 203-781-4600 Fax: 203-781-4624 | |
Beverly Brazzell, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Long Wharf Dr, New Haven, CT 06511 Phone: 203-781-4600 Fax: 203-781-4624 | |
Miss Tia Marie Edwards, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Long Wharf Dr, New Haven, CT 06511 Phone: 203-781-4600 Fax: 203-781-4624 | |
Dianna Gabrielle Celano, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 495 Congress Ave, New Haven, CT 06519 Phone: 203-752-8091 | |
Ms. Denise L Shannon, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 495 Congress Ave, New Haven, CT 06519 Phone: 203-781-4600 Fax: 203-781-4624 | |
Ms. Loretta Gibson, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 495 Congress Ave, New Haven, CT 06519 Phone: 203-781-4600 Fax: 203-781-4624 | |
Arlene O'callahan, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Long Wharf Dr, New Haven, CT 06511 Phone: 203-781-4600 Fax: 203-781-4624 |